Patent · US Active

Hepcidin analogues and uses thereof

US10030061B2 · kind B2 · utility

21Cited by
20References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 30, 2017
Grant dateJul 24, 2018
Priority date
Expiry dateNov 30, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates, inter alia, to certain hepcidin peptide analogs, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and disorders described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.